Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.678 USD | +4.31% | +6.35% | -36.07% |
06-10 | BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO | MT |
05-15 | Alaunos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-36.07% | 10.86M | |
+20.63% | 127B | |
+24.16% | 27.67B | |
-20.17% | 20.33B | |
-16.06% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- TCRT Stock
- News Alaunos Therapeutics, Inc.
- Transcript : ZIOPHARM Oncology, Inc. Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 07